Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
- Carson Tahoe Regional Medical Center — Carson City, Nevada
- Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
- OptumCare Cancer Care at Charleston — Las Vegas, Nevada
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
- Comprehensive Cancer Centers of Nevada - Central Valley — Las Vegas, Nevada